As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: March 8, 2012
by McGill University for EurekAlert
New study points to possible new therapeutic approaches in treatment
A research group led by Dr. A. Claudio Cuello of McGill University’s Faculty of Medicine, Dept. of Pharmacology and Therapeutics, has uncovered a critical process in understanding the degeneration of brain cells sensitive to Alzheimer’s disease (AD). The study, published in the February issue of the Journal of Neuroscience, suggests that this discovery could help develop alternative AD therapies.
A breakdown in communication between the brain’s neurons is thought to contribute to the memory loss and cognitive failure seen in people with AD. The likely suspect is NGF (Nerve Growth Factor), a molecule responsible for generating signals that maintain healthy cholinergic neurons – a subset of brain cells that are particularly sensitive to AD – throughout a person’s lifetime. Oddly, scientists had never been able to find anything wrong with this molecule to explain the degeneration of cholinergic neurons in patients with AD.
This new study, however, has elucidated the process by which NGF is released in the brain, matures to an active form and is ultimately degraded. The researchers were also able to determine how this process is altered in AD. The group demonstrated that treatment of healthy adult rats with a drug that blocks the maturation of active NGF leads to AD-like losses of cholinergic functional units, which result in cognitive impairments. By contrast, when treated with a drug to prevent degradation of active NGF, the numbers of cholinergic contacts increased significantly.
“Part of the difficulty in understanding this pathway has been due to the technical challenges associated with differentiating the active and inactive forms of NGF,” explained Dr. Simon Allard, the study’s lead author and a postdoctoral fellow at McGill. “Our proposed manipulations are different from existing therapies as they aim to protect neurons from degeneration.”
The authors suggest that these findings may lead to pharmacological treatments that could delay the progression of Alzheimer’s disease. “This discovery should help design alternative therapies,” said Dr. Cuello, a Charles E. Frosst / Merck Chair.
It’s no secret that if you want to keep your mind sharp, it’s worth making some time to workout. Yes, exercise won’t only give you a sexy body. It’ll help get you a sexy brain as well....
Depression is a constant sadness affecting our activity level, behavior, thoughts, feelings, and sense of well-being. Those affected often feel empty and worthless, which could lead to erratic behavior or even suicide. There are numerous...
One in three cases of dementia could be prevented if more people looked after their brain health throughout life, according to an international study in the Lancet. It lists nine key risk factors including lack...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.